The Harvard Law School Corporate Governance and Financial Regulation blog is getting a workout in the wake of the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) / Pershing Square efforts to team up to purchase Allergan, Inc. (NYSE:AGN).
Pershing Square partnered with Valeant to acquire Allergan
In that episode, the activist hedge fund Pershing Square partnered with Valeant, providing them access to inside knowledge that Valeant was going to engage in a takeover bid for Allergan. Pershing Square invested in Allergan, Inc. (NYSE:AGN) before the news was public, pulling down nearly $2 billion in profits. The move was said to cause considerable consternation among regulators at the Securities and Exchange Commission. In fact one such
Setup a free account to get access to this article (no credit card required).Login required to continue reading.
